ArticleMolecular pharmaceutics2026
Intracranial Human BT12 Glioblastoma Xenograft is [
David Ekwe, Abiodun Ayo, Xiaoqing Zhuang, Pyry Dillemuth, Tomi T Airenne, Emel Bakay, Petter Lövdahl, Jonne Kunnas, Lu Bai, Johan Rajander and 4 more
Abstract read
In one paragraphArticle in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
David EkweTurku PET Centre, University of Turku, 20521 Turku, Finland.
Abiodun AyoTranslational Cancer Medicine Research Program, Facuty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Xiaoqing ZhuangTurku PET Centre, University of Turku, 20521 Turku, Finland.
Pyry DillemuthTurku PET Centre, University of Turku, 20521 Turku, Finland.
Tomi T AirenneStructural Bioinformatics Laboratory and InFLAMES Research Flagship, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland.
Emel BakayTurku PET Centre, University of Turku, 20521 Turku, Finland.
Petter LövdahlTurku PET Centre, University of Turku, 20521 Turku, Finland.
Lu BaiTurku PET Centre, University of Turku, 20521 Turku, Finland.
Tiina A SalminenStructural Bioinformatics Laboratory and InFLAMES Research Flagship, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland.ORCID 0000-0002-4135-8020 Jessica M RosenholmPharmaceutical Sciences Laboratory, Department of Natural and Health Sciences, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland.ORCID 0000-0001-6085-1112 Pirjo LaakkonenTranslational Cancer Medicine Research Program, Facuty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-9620-095X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Glioblastoma is the most aggressive primary brain tumor in adults with a median survival of less than 2 years. Radiolabeled amino acids like
Indexed as
Brain NeoplasmsGlioblastomaPositron-Emission TomographyRadiopharmaceuticalsTyrosineAnimalsCell Line, TumorFemaleHumansMiceMice, NudeMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPyrimidinonesSymportersThiophenes(18F)fluoroethyltyrosineAZD3965Monocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPyrimidinonesRadiopharmaceuticalsSymportersThiophenesTyrosine[18F]FET6-[18F]fluoronicotinic acidfluorine-18glioblastomamonocarboxylate transporterspositron emission tomography
Identifiers
PMID42261079
PMCPMC13343506
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390